Skip to content

Medical-device intelligence

GIL: Plasma, Fibrinogen Control

FDA product code GIL: Plasma, Fibrinogen Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GIL
FDA device name
Plasma, Fibrinogen Control
Device class
2
Regulation number
864.7340
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 0 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Nov 3, 1983 to Jul 29, 1996.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GIL · Plasma, Fibrinogen Control80

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
N/T PROTEIN CONTROL PYK962407 · GILBehring Diagnostics, Inc.510(k)Jul 29, 1996FDA decision date
FIBRINOGEN CONTROL (HUMAN) LEVEL 1, 2, 3K946193 · GILMore Diagnostics510(k)Aug 24, 1995FDA decision date
FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3K946265 · GILClinical Controls, Inc.510(k)Aug 24, 1995FDA decision date
PLASMA FIBRINOGEN CONTROL LEVEL 1/LEVEL 2K935598 · GILClinical Controls, Inc.510(k)May 2, 1995FDA decision date
N/T PROTEIN CONTROL PYK951012 · GILBehring Diagnostics, Inc.510(k)Apr 17, 1995FDA decision date
LIQUID FIBRINOGEN FDP CONTROL LEVEL 1 & 2K934741 · GILClinical Controls, Inc.510(k)Sep 8, 1994FDA decision date
FIBRINOGEN CONTROLK915462 · GILSigma Diagnostics, Inc.510(k)Mar 4, 1992FDA decision date
GEN. DIAGNOSTICS LOW FIBRINOGEN CONTROLK833352 · GILWarner-Lambert Co.510(k)Nov 3, 1983FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗